Fusion Pharmaceuticals Appoints New Chief Medical Officer
Hamilton, Ontario. 23 March 2020. Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines to treat a broad range of cancers, today announced the appointment of James J. O’Leary, M.D., as chief medical officer (CMO). “With his extensive experience and skills as a medical oncologist and […]
Fusion Pharmaceuticals Appoints New Chief Medical Officer Read More »